Cost and morbidity associated with antibiotic prophylaxis in the ICU

N Namias1, S Harvill, S Ball

  • 1Department of Surgery, University of Miami School of Medicine, FL 33101, USA.

Abstract

Insights

Prolonged prophylactic antibiotic (PA) use beyond 24 hours is common and costly. Extended PA courses (over 4 days) were linked to increased rates of bacteremia and line infections in surgical patients.

Area of Science:

  • Infectious Diseases
  • Hospital Pharmacy
  • Surgical Critical Care

Background:

  • High costs and misuse of antibiotics are known issues.
  • Data on infectious morbidity from prolonged prophylactic antibiotics (PA) were previously lacking.

Purpose of the Study:

  • To investigate the association between prolonged prophylactic antibiotic use and infectious morbidity.
  • To quantify the cost implications of non-compliance with short-course PA protocols.

Main Methods:

  • Retrospective review of antibiotic orders from a Surgical Intensive Care Unit microbiology database (1995-1997).
  • Calculation of costs associated with PA exceeding 1 day.
  • Comparison of bacteremia and line infection rates between patients receiving ≤1 day vs. >4 days of PA.

Main Results:

  • 61% of PA orders were continued beyond 1 day.
  • The cost of PA beyond 1 day was $44,893.
  • Higher frequencies of bacteremia and line infections were observed in patients receiving >4 days of PA.

Conclusions:

  • Poor adherence to 24-hour PA protocols was identified.
  • Non-compliance incurred significant costs ($44,893).
  • Prolonged PA (>4 days) correlated with increased rates of bacteremia and line infections.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...